Catalysts for Watson Inc
19 tracked
Apr 14, 2026
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Apr 14, 2026
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Mar 3, 2026
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Feb 17, 2026
approval
AMBRISENTAN โ FDA approval
AMBRISENTAN
โ
Dec 29, 2025
approval
SITAGLIPTIN PHOSPHATE โ FDA approval
SITAGLIPTIN PHOSPHATE
โ
Nov 5, 2025
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Apr 4, 2025
approval
AMBRISENTAN โ FDA approval
AMBRISENTAN
โ
Feb 21, 2025
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Jan 23, 2025
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Jan 23, 2025
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Sep 17, 2024
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Aug 19, 2024
approval
AMBRISENTAN โ FDA approval
AMBRISENTAN
โ
Apr 29, 2022
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Jun 8, 2021
approval
AMBRISENTAN โ FDA approval
AMBRISENTAN
โ
Dec 22, 2020
approval
AMBRISENTAN โ FDA approval
AMBRISENTAN
โ
Nov 29, 2019
approval
AMBRISENTAN โ FDA approval
AMBRISENTAN
โ
Nov 4, 2019
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Apr 26, 2019
approval
BOSENTAN โ FDA approval
BOSENTAN
โ
Mar 28, 2019
approval
AMBRISENTAN โ FDA approval
AMBRISENTAN
โ